These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 30426359)
21. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051 [TBL] [Abstract][Full Text] [Related]
22. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2. Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877 [TBL] [Abstract][Full Text] [Related]
23. A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findings. Bitoun M; Stojkovic T; Prudhon B; Maurage CA; Latour P; Vermersch P; Guicheney P Neuromuscul Disord; 2008 Apr; 18(4):334-8. PubMed ID: 18394888 [TBL] [Abstract][Full Text] [Related]
24. Dynamin 2 and human diseases. Durieux AC; Prudhon B; Guicheney P; Bitoun M J Mol Med (Berl); 2010 Apr; 88(4):339-50. PubMed ID: 20127478 [TBL] [Abstract][Full Text] [Related]
33. A new mutation in DNM2 gene in a large Italian family. Lopergolo D; Bocci S; Pinto AM; Valentino F; Doddato G; Ginanneschi F; Volpi N; Renieri A; Giannini F Neurol Sci; 2021 Jun; 42(6):2509-2513. PubMed ID: 33459893 [TBL] [Abstract][Full Text] [Related]
34. Dynamins in human diseases: differential requirement of dynamin activity in distinct tissues. Laiman J; Lin SS; Liu YW Curr Opin Cell Biol; 2023 Apr; 81():102174. PubMed ID: 37230036 [TBL] [Abstract][Full Text] [Related]
35. Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China. Chen T; Pu C; Wang Q; Liu J; Mao Y; Shi Q Neurol Sci; 2015 May; 36(5):735-41. PubMed ID: 25501959 [TBL] [Abstract][Full Text] [Related]
36. Imaging-based evaluation of pathogenicity by novel DNM2 variants associated with centronuclear myopathy. Fujise K; Okubo M; Abe T; Yamada H; Takei K; Nishino I; Takeda T; Noguchi S Hum Mutat; 2022 Feb; 43(2):169-179. PubMed ID: 34837441 [TBL] [Abstract][Full Text] [Related]
37. Mutational and clinical spectrum of centronuclear myopathy in 9 cases and a literature review of Chinese patients. Wang Q; Yu M; Xie Z; Liu J; Wang Q; Lv H; Zhang W; Yuan Y; Wang Z Neurol Sci; 2022 Apr; 43(4):2803-2811. PubMed ID: 34595679 [TBL] [Abstract][Full Text] [Related]
38. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients. Zhao Y; Zhao Z; Shen H; Bing Q; Hu J Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666 [TBL] [Abstract][Full Text] [Related]
39. Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathy. F Almeida C; Bitoun M; Vainzof M FASEB J; 2021 Apr; 35(4):e21346. PubMed ID: 33715228 [TBL] [Abstract][Full Text] [Related]
40. Dynamin-2 mutations associated with centronuclear myopathy are hypermorphic and lead to T-tubule fragmentation. Chin YH; Lee A; Kan HW; Laiman J; Chuang MC; Hsieh ST; Liu YW Hum Mol Genet; 2015 Oct; 24(19):5542-54. PubMed ID: 26199319 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]